arrow
F

Florian Kaiser

oncological practice
H指数:29
被引数:4,541

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Impact of Sex on Efficacy and Safety of 1st-Line Treatment with FOLFIRI plus Cetuximab or Bevacizumab in RAS/BRAF Wildtype Metastatic Colorectal Cancer– A subgroup analysis of the FIRE-3 (AIO KRK-0306) Trial

性別对FOLFIRI联合西妥昔单抗或贝伐珠单抗作为RAS/BRAF野生型转移性结直肠癌一线治疗方案有效性和安全性的影响——FIRE-3 (AIO KRK-0306)试验的亚组分析

2025-11-220
PRE
First-line treatment efficacy of anti-EGFR versus anti-VEGF antibodies in BRAFV600E-mutated metastatic colorectal cancer according to primary tumor sidedness: a pooled analysis of seven clinical trials performed in the first-line treatment of mCRC (German AIO Study Group)

抗EGFR抗体与抗VEGF抗体在BRAFV600E突变型转移性结直肠癌中根据原发肿瘤侧性的初始治疗疗效:一项在mCRC初始治疗中进行的七项临床试验的合并分析(德国AIO研究组)

2025-11-130
OAAI
Risk of disease progression in the first-line therapy of metastatic colorectal cancer to guide disease re-assessments - analysis of eleven trials by AIO and GONO

转移性结直肠癌一线治疗中疾病进展的风险,以指导疾病再评估——AIO和GONO对11项试验的分析

2025-08-190
OAAI
The Surface-Topography Challenge: A Multi-Laboratory Benchmark Study to Advance the Characterization of Topography

表面形貌挑战:一项多实验室基准研究以推进形貌表征

2025-07-260
OA
Evaluation of circulating tumor DNA as a prognostic and predictive biomarker in BRAF V600E mutated colorectal cancer-results from the FIRE-4.5 study
2024-12-040
PRE
Evaluation of risk of disease progression in first-line therapy of unresected metastatic colorectal cancer to guide intervals of radiological assessment: An analysis of eleven randomized trials by AIO and GONO

评估不可切除的转移性结直肠癌一线治疗中疾病进展风险的评估,以指导放射学评估的间隔:AIO和GONO进行的十一项随机试验的分析

2024-09-010
PRE
First-line fluoropyrimidine plus bevacizumab followed by irinotecan-escalation versus initial fluoropyrimidine, irinotecan and bevacizumab in patients with metastatic colorectal cancer - Final survival and per-protocol analysis of the randomised XELAVIRI trial (AIO KRK 0110)
2022-09-012
PRE
FOLFOX plus panitumumab or FOLFOX alone as additive therapy following R0/1 resection of RAS wild-type colorectal cancer liver metastases - The PARLIM trial (AIO KRK 0314)

FOLFOX加帕尼单抗或FOLFOX单独作为RAS野生型结直肠癌肝转移基本传染数/1切除后的附加疗法-PARLIM试验 (AIO KRK 0314)

2022-09-014
PRE
Study protocol of the FIRE-8 (AIO-KRK/YMO-0519) trial: a prospective, randomized, open-label, multicenter phase II trial investigating the efficacy of trifluridine/tipiracil plus panitumumab versus trifluridine/tipiracil plus bevacizumab as first-line treatment in patients with metastatic colorectal cancer
2022-07-277
OAAI
Single-nucleotide variants, tumour mutational burden and microsatellite instability in patients with metastatic colorectal cancer: Next-generation sequencing results of the FIRE-3 trial (vol 137, pg 250, 2020)
2022-07-011
PRE